Spinventure
6
5M
6
1
- Areas of investment
Summary
The company was established in Europe in Belgium. The main office of represented VC is situated in the Angleur.
Among the most popular fund investment industries, there are Therapeutics, Health Care. Among the most popular portfolio startups of the fund, we may highlight DIM3, Okapi Sciences, Convert Pharmaceuticals. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Spinventure, startups are often financed by Spreds, Meusinvest, Inventures SA. The meaningful sponsors for the fund in investment in the same round are Spreds, Meusinvest, Inventures SA. In the next rounds fund is usually obtained by Walloon, The Institute for the Promotion of Innovation by Science and Technology in Flanders.
This Spinventure works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2014.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Biotechnology (4)
- Health Care (3)
- Therapeutics (2)
- Medical (2)
- Medical Device (2) Show 4 more
- Investments by region
-
- Belgium (5)
- United States (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Convert Pharmaceuticals | 28 Feb 2018 | Biotechnology, Pharmaceutical, Business Development | Early Stage Venture | 16M | Liège, Liège, Belgium |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.